Key result
Percutaneous PDA closure decreases LVEF by ~4% alongside reduced left ventricular and atrial sizes.
Why the study?
The extent of cardiac remodeling following percutaneous PDA closure in adults is not well understood.
Does percutaneous PDA closure induce cardiac remodeling in adults?
Meta-Analysis (n=244)
Yes
Does percutaneous PDA closure induce cardiac remodeling in adults?
Mean Difference: -3.95 (95% CI -5.8–-2.09)
Absolute Event Rate: 60% vs 64%
Percutaneous PDA closure in adults leads to significant reductions in left ventricular and left atrial sizes, accompanied by a decrease in LVEF that remains lower than baseline at follow-up.
Supports favorable remodeling after adult PDA closure; extends limited observational data with first pooled echocardiographic synthesis.
While percutaneous closure is preferred in adults with a patent ductus arteriosus (PDA), the extent of cardiac remodeling following percutaneous PDA closure in adults is not well understood. We performed a meta-analysis to characterize cardiac remodeling following percutaneous PDA closure in adults. MEDLINE and EMBASE were systematically searched for original studies that reported echocardiographic variables at baseline, immediately post-procedure (24 h), and at follow-up (>1 month) in adults undergoing percutaneous PDA closure. Additionally, we included data from patients >18 years of age that underwent percutaneous PDA closure between January 2015–December 2019 at our centre. Weighted averages were calculated for parameters with sufficient data. Pooled differences were presented as weighted mean differences (WMD). After screening 278 abstracts, 5 studies were identified. When combined with our cohort, our meta-analysis encompassed 244 patients. Immediately post-procedure, LVEF was the only parameter to change significantly (64 vs 52%, WMD -8.64 95%, CI -14.04 to −3.25). All parameters significantly decreased from baseline to follow-up: LVEF: 64 vs 60% (WMD -3.95, CI -5.80 to −2.09), LVEDD: 62 vs 53 mm (WMD -8.79, CI -12.78 to −4.81) LVEDVI 172 vs 123 mL/m2 (WMD -26.60, CI -45.4 to −7.85), LVESD 42 vs 36 mm (WMD -4.64, CI -9.10 to −0.17) and LA dimension: 42 vs 37 mm (WMD -5.87, CI -9.85 to −1.90). As compared to the baseline values, left ventricular and left atrial sizes decreased. The LVEF decreased immediately following PDA closure and, while it recovers, it remained lower on follow-up testing.
No takes yet. Share an insight, caveat, or question.
Blissett et al. (2021) conducted a meta-analysis in Patent ductus arteriosus (PDA) (n=244). Percutaneous PDA closure vs. Baseline was evaluated on LVEF change from baseline to follow-up (WMD -3.95, 95% CI -5.80 to -2.09). Percutaneous PDA closure in adults significantly decreased LVEF from baseline to follow-up (64% vs 60%; WMD -3.95, 95% CI -5.80 to -2.09), alongside reductions in left ventricular and atrial sizes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: